2023 - Research.com Medicine in Japan Leader Award
2023 - Research.com Genetics in Japan Leader Award
Seishi Ogawa mainly investigates Immunology, Genetics, Cancer research, Leukemia and Mutation. His research in Immunology intersects with topics in Hematopoietic stem cell transplantation, Haematopoiesis, Stem cell and Transplantation. Seishi Ogawa interconnects Somatic cell, Loss of heterozygosity, Lymphoma, Tumor suppressor gene and Epigenetics in the investigation of issues within Cancer research.
His Leukemia research incorporates themes from Myeloid, Germline mutation, Myeloid leukemia and Pancytopenia. His studies deal with areas such as Molecular biology, Internal medicine and NPM1 as well as Mutation. His Gene study combines topics in areas such as Cancer and Epithelium.
Seishi Ogawa mainly focuses on Cancer research, Genetics, Internal medicine, Mutation and Leukemia. Seishi Ogawa studies Myeloid leukemia, a branch of Cancer research. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Oncology.
His Mutation research incorporates elements of Somatic cell and Somatic evolution in cancer. Myelodysplastic syndromes is closely connected to Myeloid in his research, which is encompassed under the umbrella topic of Leukemia. The various areas that Seishi Ogawa examines in his Immunology study include Haematopoiesis and Allele.
Seishi Ogawa spends much of his time researching Cancer research, Internal medicine, Mutation, Oncology and Gene. His Cancer research study incorporates themes from Cancer, Leukemia and Haematopoiesis. His Haematopoiesis research is multidisciplinary, incorporating elements of Progenitor cell, Human leukocyte antigen and Immunology.
His research combines Gene mutation and Internal medicine. In his study, Transcription factor is strongly linked to Cell biology, which falls under the umbrella field of Mutation. Gene is a subfield of Genetics that Seishi Ogawa explores.
His primary scientific interests are in Cancer research, Mutation, Gene, Internal medicine and Myeloid. His Cancer research research includes themes of Exome sequencing, Carcinogenesis, Cancer, Transcriptome and Lymphoma. His Mutation research is multidisciplinary, incorporating perspectives in Somatic cell, Immune system, Somatic evolution in cancer, Biopsy and Cell biology.
His Gene study introduces a deeper knowledge of Genetics. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Oncology, Gene mutation and NPM1. His Myeloid study combines topics from a wide range of disciplines, such as Haematopoiesis, Myeloid leukemia, Exome, Leukemia and Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida;Masashi Sanada;Yuichi Shiraishi;Daniel Nowak.
Nature (2011)
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
T Haferlach;Y Nagata;V Grossmann;Y Okuno.
Leukemia (2014)
Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
Michiko Mandai;Akira Watanabe;Yasuo Kurimoto;Yasuhiko Hirami.
The New England Journal of Medicine (2017)
Oncogenic mutations of ALK kinase in neuroblastoma.
Yuyan Chen;Junko Takita;Young Lim Choi;Motohiro Kato.
Nature (2008)
Control of carrier density by self-assembled monolayers in organic field-effect transistors
S. Kobayashi;T. Nishikawa;T. Nishikawa;T. Takenobu;S. Mori.
Nature Materials (2004)
Integrated molecular analysis of clear-cell renal cell carcinoma.
Yusuke Sato;Tetsuichi Yoshizato;Yuichi Shiraishi;Shigekatsu Maekawa.
Nature Genetics (2013)
KIF5B-RET fusions in lung adenocarcinoma.
Takashi Kohno;Hitoshi Ichikawa;Yasushi Totoki;Kazuki Yasuda.
Nature Medicine (2012)
A Robust Algorithm for Copy Number Detection Using High-Density Oligonucleotide Single Nucleotide Polymorphism Genotyping Arrays
Yasuhito Nannya;Masashi Sanada;Kumi Nakazaki;Noriko Hosoya.
Cancer Research (2005)
A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner.
R Sakai;A Iwamatsu;N Hirano;S Ogawa.
The EMBO Journal (1994)
Mutational landscape and clonal architecture in grade II and III gliomas
Hiromichi Suzuki;Kosuke Aoki;Kenichi Chiba;Yusuke Sato.
Nature Genetics (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Tokyo Medical and Dental University
University of Tokyo
Kyoto University
University of Tsukuba
Cedars-Sinai Medical Center
University of Tokyo
Nagoya University
Cleveland Clinic
Gunma Children's Medical Center
Cleveland Clinic
Technical University of Denmark
University of Bologna
Carnegie Mellon University
University of California, Riverside
Stryker Instruments
University of British Columbia
National Cancer Research Institute, UK
University of Michigan–Ann Arbor
Taipei Medical University
Tel Aviv University
University of Minnesota
Karlsruhe Institute of Technology
Goddard Space Flight Center
Oslo University Hospital
KU Leuven
The University of Texas Southwestern Medical Center